|Last Price$0.16||Day Change (%)0%|
|Open Price$0.16||Day Change ($)0.00|
|Day Range0.16–0.16||52-Week Range0.13–7.20|
As of Wed 12/24/2014 12:59 PM EST | USD
IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics
Mylan Launches First Generic Version of Vivelle-DOT®
IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit
Fitch Affirms Teva's Ratings at 'BBB+'; Outlook Stable
Cegedim: EBIT from Recurring Operations Grew in Third Quarter 2014
Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.